These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38109873)

  • 1. Extracorporeal Techniques in Kidney Failure.
    Meijers B; Vega A; Juillard L; Kawanishi H; Kirsch AH; Maduell F; Massy ZA; Mitra S; Vanholder R; Ronco C; Cozzolino M;
    Blood Purif; 2024; 53(5):343-357. PubMed ID: 38109873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential convective therapies (SCT): a prospective study on feasibility, safety, adequacy and tolerance of on-line hemofiltration and hemodiafiltration in sequence.
    Petras D; Fortunato A; Soffiati G; Brendolan A; Bonello M; Crepaldi C; Ratanarat R; Campolo G; Amato M; Ronco C
    Int J Artif Organs; 2005 May; 28(5):482-8. PubMed ID: 15883963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical milestones of a long pathway.
    Roy T
    Contrib Nephrol; 2011; 175():1-14. PubMed ID: 22188683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended Daily Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury: A Meta-analysis.
    Zhang L; Yang J; Eastwood GM; Zhu G; Tanaka A; Bellomo R
    Am J Kidney Dis; 2015 Aug; 66(2):322-30. PubMed ID: 25843704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow continuous hemofiltration and slow continuous ultrafiltration.
    Paganini EP
    ASAIO Trans; 1988; 34(1):63-6. PubMed ID: 3377916
    [No Abstract]   [Full Text] [Related]  

  • 6. New experiences with the therapy of acute kidney injury.
    Kes P; Basić Jukić N
    Prilozi; 2008 Dec; 29(2):119-53. PubMed ID: 19259043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Producing on-line ultrapure dialysis fluid.
    von Albertini B
    Contrib Nephrol; 2011; 175():46-56. PubMed ID: 22188687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Am J Kidney Dis; 2014 Jun; 63(6):954-67. PubMed ID: 24434188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performance, intermediate and long-term outcomes of high-volume hemodiafiltration in patients with kidney failure.
    Guedes M; Vernooij RWM; Davenport A; Kuhlmann MK; Aregger F; Pecoits-Filho R
    Semin Dial; 2022 Sep; 35(5):420-426. PubMed ID: 35689437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.
    Meyer TW; Walther JL; Pagtalunan ME; Martinez AW; Torkamani A; Fong PD; Recht NS; Robertson CR; Hostetter TH
    Kidney Int; 2005 Aug; 68(2):867-77. PubMed ID: 16014068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine reduction rate in internal haemodiafiltration-a comparison with other mixed dialysis therapies.
    Righetti M; Ferrario GM; Serbelloni P; Milani S; Tommasi A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2034-5. PubMed ID: 16524932
    [No Abstract]   [Full Text] [Related]  

  • 15. Techniques of continuous arteriovenous hemofiltration and hemodialysis. Renal replacement in the ICU for hypervolemic, uremic patients.
    Merrill RH
    J Crit Illn; 1991 Apr; 6(4):381-7. PubMed ID: 10147916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence.
    Thomas G; Jaber BL
    Semin Dial; 2009; 22(6):610-4. PubMed ID: 20017830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting urea clearance during continuous hemodiafiltration in the canine model.
    Hiyama DT; Weiss RG; Ryckman FC
    J Pediatr Surg; 1989 Aug; 24(8):756-9. PubMed ID: 2769542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.
    Krieter DH; Lemke HD; Canaud B; Wanner C
    Biochim Biophys Acta; 2005 Nov; 1753(1):146-53. PubMed ID: 16154809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dialysis technology in the removal of uremic toxins.
    Davenport A
    Hemodial Int; 2011 Oct; 15 Suppl 1():S49-53. PubMed ID: 22093601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.